Related Articles
CCNA2 and NEK2 regulate glioblastoma progression by targeting the cell cycle
Gene expression profiling and the isocitrate dehydrogenase mutational landscape of temozolomide‑resistant glioblastoma
Molecular biomarkers and integrated pathological diagnosis in the reclassification of gliomas
Clinical implications of hypoxia‑inducible factor‑1α and caveolin‑1 overexpression in isocitrate dehydrogenase‑wild type glioblastoma multiforme
Nomogram for predicting the survival of patients with malignant melanoma: A population analysis